Matthew Brams - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Matthew Brams has filed 1 SEC Form 4 filing across 1 company in the last 90 days - buying. Lifetime open-market purchases: $10K.
Profile
Matthew Brams serves as EVP and Chief Medical Officer of Cingulate Inc. (CING). Brams has reported 5 insider filings with the SEC since 2024. The most recent filing was in July 2026.
| Role | EVP and Chief Medical Officer |
|---|---|
| Notability | 34/100 |
Board memberships
- Cingulate Inc.
Reported roles
- EVP and Chief Medical Officer
Trading Pattern
InsiderAlpha's records for Matthew Brams go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. The typical open-market purchase is $5K (2 buys totaling $10K). The largest single buy on record is $10K of CING in 2026. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Matthew Brams has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- EVP and Chief Medical Officer at Cingulate Inc. (CING) - 5 filings, 2024 to 2026
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-12 | CING | Cingulate Inc. | F - Tax withholding / forfeiture | 1.0K | $0.00 | |
| 2026-03-12 | CING | Cingulate Inc. | A - Grant or award | 4.5K | $0.00 | |
| 2026-02-11 | CING | Cingulate Inc. | P - Open-market purchase | 1.9K | $5.04 | $10K |
Companies - Last 90 Days
- Cingulate Inc. (CING) - 1 filing, last 2026-07-20
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Matthew Brams has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- Thomas Jeffrey Hargroves - $498K of CING open-market activity in the last 12 months
- Peter J. Werth - $100K of CING open-market activity in the last 12 months
- Shane J. Schaffer - $35K of CING open-market activity in the last 12 months
- Jennifer L. Callahan - $25K of CING open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Neil Mehta
- Keith A. Meister
- MetLife Investment Management, LLC
- John Micek
- Andrew J. Mills
- Charles N. Mills
- Kevin J. Mills
- Mink Brook Asset Management LLC
Frequently Asked Questions
Who is Matthew Brams?
Matthew Brams serves as EVP and Chief Medical Officer of Cingulate Inc. (CING). Brams has reported 5 insider filings with the SEC since 2024. The most recent filing was in July 2026.…
How many SEC Form 4 filings has Matthew Brams submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew Brams been buying or selling stock?
Recorded transactions: 2 open-market purchases ($10K) and 0 open-market sales across all tracked filings.
Where can I see all of Matthew Brams's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Matthew Brams profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.